Purchase Order 75N92B18P00016
Award Date 6/19/18
Potential Completion Date 7/19/18
Potential Value $22K
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94566, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on July 5, 2018. Place of performance is Pleasanton, California. The order covers genomic analysis instruments, consumables, or bioinformatics software supplied by the vendor. No set-aside applied. Ultimate completion date is July 5, 2018.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on August 2, 2018, with completion by August 30, 2018. Work is performed in Pleasanton, California. The order is for commercial genomic analysis instruments, consumables, or reagents supplied on a firm fixed price basis. No set-aside applies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,509.00 on July 9, 2018, with completion on July 8, 2019. Performance took place in Pleasanton, California. The order was issued on a firm fixed price basis with no small business set-aside. The source does not specify the items or services procured.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,534.00 on August 7, 2018. Performance is located in Pleasanton, California. The order period runs from August 7, 2018 through August 6, 2019. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $22,310.60 on February 19, 2019, with completion on February 18, 2020. No set-aside was used. Performance occurs in Pleasanton, California. The order is priced on a firm fixed price basis for commercial genomic analysis instruments, consumables, or bioinformatics software supporting the institute's research operations.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $21,136.00 on April 3, 2019, with final completion on April 26, 2019. No set-aside was used. Place of performance is Yountville, California. The order covers genomic analysis instrumentation, consumables, or reagent kits supplied under firm fixed price terms.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $24,119.00 on March 5, 2020, with completion by March 12, 2020. No set-aside was used. Performance occurred in Pleasanton, California. The order was issued on a firm fixed price basis for genomic analysis products and related supplies.</p>
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $19,100.00 on August 23, 2018. No set-aside was applied. Place of performance is Bethesda, Maryland. The order was completed by August 22, 2019. Pricing was firm fixed price for commercial genomic analysis instruments, consumables, or reagents—10X Genomics' core product portfolio in single-cell and spatial transcriptomics platforms supplied to federal research agencies.
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,285.50 on September 10, 2019, with completion by September 9, 2020. No set-aside applied. Work is performed at Bethesda, Maryland. The order is priced on a firm fixed price basis for genomic analysis instruments, consumables, or reagents consistent with the vendor's product portfolio of single-cell and spatial transcriptomics platforms and associated kits.